Skip to main content

Table 3 30-day and 1-year clinical outcomes

From: Higher incidence of perivalvular abscess determines perioperative clinical outcome in patients undergoing surgery for prosthetic valve endocarditis

 ENTIRE COHORTPROPENSITY MATCHED COHORT
NVE (n = 315)PVE (n = 103)P valueNVE (n = 315)PVE
(n = 103)
P value
30-DAY OUTCOME
 30-day mortality26(8.3%)22(21.4%)< 0.0014(5.1%)16(20.3%)0.004
 Myocardial infarction1(0.3%)1(1.0%)0.4390(0%)1(1.3%)0.238
 New pacemaker *23(7.3%)20(19.4%)< 0.0018(10.1%)11(13.9%)0.463
 New postoperative cerebrovascular events15(4.8%)8(7.8%)0.2526(7.6%)4(5.1%)0.499
Stroke14(4.4%)5(4.9%)0.8626(7.6%)3(3.8%)0.294
Intracranial bleeding1(0.3%)3(2.9%)0.0770(0%)1(1.3%)0.238
 Postoperative AKI107(34.0%)47(45.6%)0.03533(41.8%)32(40.5%)0.872
 Re-exploration for bleeding45(14.3%)26(25.2%)0.00910(12.7%)17(21.5%)0.129
 Tracheostomy38(12.1%)21(20.4%)0.03610(12.7%)15(19.0%)0.276
 Time of ventilation (h)18.2[11–68]32.8[17–120]< 0.00116.8[12–46]28.3[15–113]0.017
 ICU stay (d)4.0[2.0–8.0]5.0[3.0–13.0]0.0093.0[1.0–6.0]5.0[2.0–12.0]0.042
 Hospital stay (d)12.0[8.0–16.0]14.5[10.0–20.0]0.00712.0[7.0–17.0]15.0[11.0–20.0]0.015
1-YEAR OUTCOME
 1-year mortality53(16.8%)34(33.0%)< 0.00111(13.9%)23(29.1%)0.020
 Re-admission to hospital94(29.8%)33(32.0%)0.47831(39.2%)23(29.1%)0.835
 Relapse of endocarditis10(3.2%)3(2.9%)0.9383(3.8%)2(2.5%)1.000
 New pacemaker*5(1.6%)4(3.9%)0.1772(2.5%)1(1.3%)0.792
 AKI during follow-up23(7.3%)13(12.6%)0.07111(13.9%)8(10.1%)0.883
  1. Data presented as mean ± standard deviation, number (percent) or median [IQR], respectively. AKI, acute kidney injury; ICU, intensive care unit; IQR, interquartile range; TIA, transient ischemic attack; * for AV-higher grade